ConductScience.org, home

Paper20882002

HIV: Antibodies with a split personality.

Plückthun A. Nature, 2010. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. HIV: Antibodies with a split personality. Papers, record 20882002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20882002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HIV: Antibodies with a split personality.
PubMed
Journal
Nature
PubMed
Year
2010
PubMed
Publication types
Comment, News
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Plückthun AAndreas

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody AffinityMajor topic
Antigen-Antibody ReactionsMajor topic
EpitopesMajor topic
HIV AntibodiesMajor topic
HIV AntigensMajor topic
HIV-1Major topic
Antibodies, Neutralizing
Cardiolipins
Cross Reactions
Humans
env Gene Products, Human Immunodeficiency Virus

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on20882016Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.https://conductscience.org/library/papers/20882016

Source PubMed

Download CSV of comments and corrections

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111443883Mechanisms of virus neutralization by antibody.Curr Top Microbiol Immunol2001https://conductscience.org/library/papers/11443883PubMed
215860590Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.Science2005https://conductscience.org/library/papers/15860590PubMed
34113719The influence of polyvalency on the binding properties of antibodies.Immunochemistry1972https://conductscience.org/library/papers/4113719PubMed
420080564Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20080564PubMed
519729618Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.Science2009https://conductscience.org/library/papers/19729618PubMed
618197170The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.Nat Rev Microbiol2008https://conductscience.org/library/papers/18197170PubMed
720882016Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.Nature2010https://conductscience.org/library/papers/20882016PubMed
87510748Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.J Immunol1994https://conductscience.org/library/papers/7510748PubMed
916728975Distribution and three-dimensional structure of AIDS virus envelope spikes.Nature2006https://conductscience.org/library/papers/16728975PubMed
1019299620Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site.Science2009https://conductscience.org/library/papers/19299620PubMed
1118090039Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.AIDS2007https://conductscience.org/library/papers/18090039PubMed
1212610298Antibody multispecificity mediated by conformational diversity.Science2003https://conductscience.org/library/papers/12610298PubMed
1316160173Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.J Virol2005https://conductscience.org/library/papers/16160173PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
32561744Capturing transient antibody conformations with DNA origami epitopes.Nat Commun2020https://conductscience.org/library/papers/32561744PubMed
30443735Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later.Histochem Cell Biol2018https://conductscience.org/library/papers/30443735PubMed
28794022Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein.J Virol2017https://conductscience.org/library/papers/28794022PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20882002

GET https://conductscience.org/api/papers/v1/20882002/authors